Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CHUC NASDAQ:MDWD NYSE:RIV NASDAQ:SNDL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHUCCharlie's$0.24-6.5%$0.29$0.03▼$0.38$65.75M1.16129,070 shs140,394 shsMDWDMediWound$18.44-0.3%$17.65$14.14▼$22.50$204.44M0.2781,409 shs20,347 shsRIVRiverNorth Opportunities Fund$11.63+1.0%$12.10$10.11▼$12.79N/AN/A95,118 shs85,633 shsSNDLSNDL$2.24+0.7%$2.45$1.15▼$2.89$587.31M3.832.54 million shs1.49 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHUCCharlie's-1.14%+1.96%-25.71%+160.26%+226.22%MDWDMediWound-0.54%-4.98%+3.58%-9.00%+10.18%RIVRiverNorth Opportunities Fund-0.26%-1.29%-4.04%-7.06%-8.68%SNDLSNDL+0.91%-6.72%-11.20%+46.53%+3.26%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHUCCharlie's$0.24-6.5%$0.29$0.03▼$0.38$65.75M1.16129,070 shs140,394 shsMDWDMediWound$18.44-0.3%$17.65$14.14▼$22.50$204.44M0.2781,409 shs20,347 shsRIVRiverNorth Opportunities Fund$11.63+1.0%$12.10$10.11▼$12.79N/AN/A95,118 shs85,633 shsSNDLSNDL$2.24+0.7%$2.45$1.15▼$2.89$587.31M3.832.54 million shs1.49 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHUCCharlie's-1.14%+1.96%-25.71%+160.26%+226.22%MDWDMediWound-0.54%-4.98%+3.58%-9.00%+10.18%RIVRiverNorth Opportunities Fund-0.26%-1.29%-4.04%-7.06%-8.68%SNDLSNDL+0.91%-6.72%-11.20%+46.53%+3.26%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHUCCharlie's 0.00N/AN/AN/AMDWDMediWound 2.33Hold$32.2574.89% UpsideRIVRiverNorth Opportunities Fund 0.00N/AN/AN/ASNDLSNDL 2.00Hold$4.50101.34% UpsideCurrent Analyst Ratings BreakdownLatest SNDL, RIV, CHUC, and MDWD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/13/2025MDWDMediWoundZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell10/8/2025MDWDMediWoundWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025SNDLSNDLWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025MDWDMediWoundWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025SNDLSNDLWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/3/2025SNDLSNDLAlliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$5.008/19/2025MDWDMediWoundZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 10/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHUCCharlie's$8.49M7.74N/AN/A($0.01) per share-24.30MDWDMediWound$19.86M10.30N/AN/A$2.89 per share6.38RIVRiverNorth Opportunities Fund$36.29MN/AN/AN/AN/AN/ASNDLSNDL$671.81M0.87N/AN/A$3.15 per share0.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHUCCharlie's-$4.16M$0.0124.32∞N/A19.36%-174.49%36.91%11/17/2025 (Estimated)MDWDMediWound-$30.22M-$2.64N/AN/AN/A-142.18%-96.71%-39.73%11/25/2025 (Estimated)RIVRiverNorth Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/ASNDLSNDL-$69.18M-$0.27N/AN/AN/A-10.38%-8.58%-7.23%11/4/2025 (Estimated)Latest SNDL, RIV, CHUC, and MDWD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/21/2025Q2 2025CHUCCharlie'sN/A$0.02N/A$0.02N/A$2.54 million8/14/2025Q2 2025MDWDMediWound-$0.55-$1.23-$0.68-$1.23$5.68 million$5.71 million7/31/2025Q2 2025SNDLSNDL-$0.04$0.01+$0.05$0.01$231.50 million$179.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHUCCharlie'sN/AN/AN/AN/AN/AMDWDMediWoundN/AN/AN/AN/AN/ARIVRiverNorth Opportunities Fund$1.6614.28%N/AN/AN/ASNDLSNDLN/AN/AN/AN/AN/ALatest SNDL, RIV, CHUC, and MDWD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.83%12/15/202512/15/202512/31/202510/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127712.83%11/14/202511/14/202511/28/202510/1/2025RIVRiverNorth Opportunities Fundmonthly$0.127713.01%10/15/202510/15/202510/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHUCCharlie's0.071.610.61MDWDMediWoundN/A1.481.35RIVRiverNorth Opportunities FundN/AN/AN/ASNDLSNDL0.115.033.36Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHUCCharlie's7.80%MDWDMediWound46.83%RIVRiverNorth Opportunities FundN/ASNDLSNDLN/AInsider OwnershipCompanyInsider OwnershipCHUCCharlie's20.90%MDWDMediWound9.20%RIVRiverNorth Opportunities FundN/ASNDLSNDLN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHUCCharlie's40270.57 million214.02 millionNot OptionableMDWDMediWound8011.09 million10.07 millionOptionableRIVRiverNorth Opportunities FundN/AN/AN/ANot OptionableSNDLSNDL2,516262.78 millionN/AOptionableSNDL, RIV, CHUC, and MDWD HeadlinesRecent News About These CompaniesSNDL to Release Q3 2025 Financial Results on November 4October 15, 2025 | tipranks.comSNDL to Announce Third Quarter 2025 Financial Results on November 4, 2025October 15, 2025 | globenewswire.comSNDL (NASDAQ:SNDL) Stock Price Down 7.6% - Here's WhyOctober 11, 2025 | marketbeat.comHot Picks: Investor optimism returns as cannabis sector shows signs of recoveryOctober 10, 2025 | bnnbloomberg.caBSNDL (NASDAQ:SNDL) Hits New 52-Week High - Here's What HappenedOctober 10, 2025 | marketbeat.comSNDL's (SNDL) Sell (D-) Rating Reaffirmed at Weiss RatingsOctober 9, 2025 | marketbeat.comSNDL (NASDAQ:SNDL) Trading Up 5.3% - Here's WhyOctober 7, 2025 | marketbeat.comSNDL (NASDAQ:SNDL) Downgraded to Hold Rating by Wall Street ZenOctober 4, 2025 | marketbeat.comMarket-Beating SNDL Inc. (SNDL) Attracts Stake Boost From Goldman SachsSeptember 29, 2025 | msn.comSNDL (NASDAQ:SNDL) Reaches New 1-Year High Following Analyst UpgradeSeptember 29, 2025 | marketbeat.comSNDL (NASDAQ:SNDL) Stock Rating Upgraded by Wall Street ZenSeptember 26, 2025 | marketbeat.comSNDL (NASDAQ:SNDL) Trading Down 4.7% - Here's WhySeptember 26, 2025 | marketbeat.comBest Cannabis Stocks in Canada to Watch Now: Technical Signals and Market OutlookSeptember 18, 2025 | marijuanastocks.comMSNDL Releases Second Quarter 2025 Financial and Operational ResultsSeptember 16, 2025 | insidermonkey.comSNDL Is Up Too MuchSeptember 14, 2025 | seekingalpha.com3 Marijuana Stocks For Better Gains This MonthSeptember 12, 2025 | marijuanastocks.comMThe Best Cheap Stocks Under $10 to BuySeptember 10, 2025 | zacks.comAlliance Global Partners Initiates Coverage of SNDL (SNDL) with Buy RecommendationSeptember 4, 2025 | msn.comSNDL initiated with a Buy at Alliance Global PartnersSeptember 3, 2025 | msn.comMichigan Cannabis Retailer Case Ruling Codifies Receiver PowerAugust 29, 2025 | news.bloomberglaw.comNHow’s the Market Reacting to SNDL Inc’s (SNDL) Q2 Results?August 29, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesDowngraded But Not Done: 3 Stocks Ready for a Market ComebackBy Thomas Hughes | September 24, 2025Carmax: Now is the Time to Load Up On This Used Car StockBy Thomas Hughes | September 26, 2025Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?By Ryan Hasson | October 3, 2025PayPal Stock: Why Wall Street May Be Undervaluing This GiantBy Gabriel Osorio-Mazilli | September 30, 2025General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 2025SNDL, RIV, CHUC, and MDWD Company DescriptionsCharlie's OTCMKTS:CHUC$0.24 -0.02 (-6.54%) As of 03:27 PM EasternCharlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes non-combustible nicotine-related, alternative alkaloid vapor, and hemp-derived vapor and edible products. It sells its products through distributors, specialty retailers, and third-party online resellers in the United States, the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.MediWound NASDAQ:MDWD$18.42 -0.08 (-0.44%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.RiverNorth Opportunities Fund NYSE:RIV$11.62 +0.12 (+1.00%) Closing price 03:59 PM EasternExtended Trading$11.62 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.SNDL NASDAQ:SNDL$2.24 +0.02 (+0.68%) Closing price 03:59 PM EasternExtended Trading$2.24 +0.01 (+0.45%) As of 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Is Oracle’s AI Rally Over? Wall Street Thinks ORCL Could Hit $400 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
